Standout Papers
Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
2020 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Oxidized Phospholipids Are Present on Plasminogen, Affect Fibrinolysis, and Increase Following Acute Myocardial Infarction
2012
Plasma carboxypeptidases as regulators of the plasminogen system.
1995
Sialic Acid Content of Plasminogen 2 Glycoforms as a Regulator of Fibrinolytic Activity
1995
PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke
1998
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Juvenile idiopathic arthritis
2007 Standout
Abdominal aortic aneurysm
2005 Standout
Thrombotic risk factors in pulmonary hypertension
2000
The changing landscape of atherosclerosis
2021 StandoutNature
Microparticles in atrial fibrillation: A link between cell activation or apoptosis, tissue remodelling and thrombogenicity
2013
Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
2004 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Fibrinolytic Activation Markers Predict Myocardial Infarction in the Elderly
1999
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Sulfhydryl compounds influence immunoreactivity, structure and functional aspects of lipoprotein (a)
1994
Intra-arterial Prourokinase for Acute Ischemic Stroke
1999 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity
2004
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times
1993
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Microparticles in Cancer
2010
Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1
1997
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The Antiphospholipid Syndrome
2002 Standout
3D bioprinting of tissues and organs
2014 Standout
Diabetes and Atherosclerosis
2002 Standout
Atherogenesis in transgenic mice expressing human apolipoprotein(a)
1992 Nature
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
Immunohaemostasis: a new view on haemostasis during sepsis
2017
Sickle-cell disease
2010 Standout
Polycystic Ovary Syndrome
2005 Standout
Impact of Apolipoprotein(a) Phenotypes on Long-Term Renal Transplant Survival
2001
Incidence of venous thromboembolism in hospitalized patients with COVID‐19
2020
Survey of the year 2003 commercial optical biosensor literature
2004
A survey of the year 2002 commercial optical biosensor literature
2003
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
1998
Fibrinogen and fibrin: scaffold proteins in hemostasis
2007
Atherosclerosis
2000 StandoutNature
Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers
2012
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
2007
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
2020 Standout
Disorders Associated with Antibodies to Endothelial Cells
1989
Atherosclerosis
2001 Standout
Angiostatin-converting Enzyme Activities of Human Matrilysin (MMP-7) and Gelatinase B/Type IV Collagenase (MMP-9)
1997
Survey of the year 2001 commercial optical biosensor literature
2002
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Engineered spatial patterns of FGF-2 immobilized on fibrin direct cell organization
2005
Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies
1991
Extracellular DNA traps promote thrombosis
2010 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis
1999
Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells
2004
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases
1996
Serpin Structure, Mechanism, and Function
2002 Standout
Complement C5b-9 Increases Plasminogen Binding and Activation on Human Endothelial Cells
1997
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin
1998
Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not
2000 StandoutNobel
Fluid Flow Stimulates Tissue Plasminogen Activator Secretion by Cultured Human Endothelial Cells
1989 Science
Immunology and Clinical Importance of Antiphospholipid Antibodies
1991
Three decades of messenger RNA vaccine development
2019
Specificity, diversity, and regulation in TGF-beta superfamily signaling.
1999
Focus on Extracellular Vesicles: Introducing the Next Small Big Thing
2016
Rapid Regulation of Platelet Activation In Vivo by Nitric Oxide
2004
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Severe Covid-19
2020
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
2006 Standout
Antiphospholipid antibodies and venous thromboembolism
1995
Antiphospholipid syndrome: five year follow up.
1991
Cytokine Storm
2020 Standout
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
2020 Standout
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Protein Design: Reengineering Cellular Retinoic Acid Binding Protein II into a Rhodopsin Protein Mimic
2007
Evidence for HLA-related susceptibility for stroke in children with sickle cell disease
2000
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
The Hypercoagulable States
1985
Small Apolipoprotein(a) Size Predicts Mortality in End-Stage Renal Disease
2002
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Catalytic Mechanism and Performance of Computationally Designed Enzymes for Kemp Elimination
2008 StandoutNobel
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
1991
Biodegradable Long-Circulating Polymeric Nanospheres
1994 StandoutScience
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Specificity, diversity, and regulation in TGF‐β superfamily signaling
1999
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis
1997
Plasmin-α2-antiplasmin Complex in Patients with Atrial Fibrillation
1999
Vascular origin determines plasminogen activator expression in human endothelial cells
1989
Works of Eduardo Anglés‐Cano being referenced
Bivalency of plasminogen monoclonal antibodies is required for plasminogen bridging to fibrin and enhanced plasmin formation
2002
Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7.
1997
Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines
1991
Development and clinical application of a new ELISA assay to determine plasmin–α2‐antiplasmin complexes in plasma
1996
Study of tissue‐type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen
1994
Overview on fibrinolysis: Plasminogen activation pathways on fibrin and cell surfaces
1994
Evidence of Netosis in Septic Shock-Induced Disseminated Intravascular Coagulation
2016
Kringles of the plasminogen–prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site
2001
Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertension
2002
Des microparticules cellulaires dévoilent leur fonction fibrinolytique et protéolytique
2009
The plasminogen?MMP system is more activated in the scar than in viable myocardium 3�months post-MI in the rat
2004
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
2020 Standout
Involvement of the Mural Thrombus as a Site of Protease Release and Activation in Human Aortic Aneurysms
2002
Cell‐derived microparticles: a new challenge in neuroscience
2009
The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin
1996
Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.
1979
Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
1997
Hemostasis Imbalance in Experimental Hypertension
2002
Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent Manner
2002
Pericellular plasmin induces smooth muscle cell anoikis
2003
Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
1991
Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro
2007
Interaction of Fibrin(ogen) with Apolipoprotein(a): Further Characterization and Identification of a Novel Lysine-Dependent Apolipoprotein(a)-Binding Site within the γ Chain 287−411 Region
2006
Sizing Nanomatter in Biological Fluids by Fluorescence Single Particle Tracking
2010
Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) αC-domains
2003
Release Pattern of the Vascular Plasminogen Activator and Its Inbibitor in Human Postvenous Occlusion Plasma as Assessed by a Spectrophotometric Solid-Phase Fibrin-tPA Activity Assay
1987
Experimental Study of Fibrin/Fibrin-Specific Molecular Interactions Using a Sphere/Plane Adhesion Model
2001
Identification and Cellular Localization of Plasminogen Activators from Human Glomeruli
1985
Fibrinolytic cross-talk: a new mechanism for plasmin formation
2009
Enhanced plasminogen-activator production by leukocytes in the human and murine Chediak-Higashi syndrome
1985
Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
1993
Sizing Nanomatter in Biological Fluids by Fluorescence Single Particle Tracking
2011
A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activator
1986
Synergistic Effect of Thrombin and CD40 Ligand on Endothelial Matrix Metalloproteinase-10 Expression and Microparticle Generation In Vitro and In Vivo
2012